COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Text Messaging Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03281356
Recruitment Status : Completed
First Posted : September 13, 2017
Last Update Posted : September 13, 2017
Information provided by (Responsible Party):
Manuel E. Jimenez, MD, MS, Rutgers, The State University of New Jersey

Brief Summary:
This pilot study aims to assess the acceptability, feasibility, and preliminary effectiveness of text messages designed to encourage shared reading among urban parents. We hypothesize that parents will report reading more often to their children after receiving the text messages.

Condition or disease Intervention/treatment Phase
Literacy Behavioral: Intervention Group Not Applicable

Detailed Description:
This is a single arm, pilot study. The participants enrolled will receive two text messages per week for a 4 week period (a total of 8 messages). At the end of the study period we will assess change in number of reading occurrences using a validated measure. Parents will also complete a brief acceptability survey.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 16 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Text Messaging Pilot Study to Encourage Shared Reading Among a Sample of Urban Parents.
Actual Study Start Date : May 9, 2017
Actual Primary Completion Date : June 13, 2017
Actual Study Completion Date : June 13, 2017

Arm Intervention/treatment
Experimental: Intervention Group Behavioral: Intervention Group
Participants will receive a total of 8 text messages during a 4 week period.

Primary Outcome Measures :
  1. Acceptability Survey [ Time Frame: Visit 2 (1 month) ]
    Three questions on the participants feedback on the program.

Secondary Outcome Measures :
  1. Stim Q Survey [ Time Frame: Visit 2 (1 month) ]
    The StimQ is a parent reported measure of the cognitive home environment

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  1. Preferred language either English or Spanish,
  2. Parent or legal guardian,
  3. Age ≥ 18,
  4. Willing to accept text messages

Exclusion Criteria:

  1. Individuals unable to provide consent
  2. Individuals who do not meet inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03281356

Layout table for location information
United States, New Jersey
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901
Sponsors and Collaborators
Rutgers, The State University of New Jersey
Layout table for additonal information
Responsible Party: Manuel E. Jimenez, MD, MS, Assistant Professor, Rutgers, The State University of New Jersey Identifier: NCT03281356    
Other Study ID Numbers: Pro20170000402
First Posted: September 13, 2017    Key Record Dates
Last Update Posted: September 13, 2017
Last Verified: September 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Manuel E. Jimenez, MD, MS, Rutgers, The State University of New Jersey:
Pilot Study
Early childhood development